irasia.com - Investor Relations Asia Pacific
HOME

Mesoblast Limited

Announcements / Press Releases


Please download the latest "Acrobat Reader" to view the PDF.

  • 2008-December-23
  • Appendix 3Y - Change of Director's Interest Notice (in PDF)
  • 2008-December-23
  • Appendix 3Y - Change of Director's Interest Notice (in PDF)
  • 2008-December-23
  • Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF)
  • 2008-November-27
  • Results of Annual General Meeting (in PDF)
  • 2008-November-27
  • The Year in Review Address by Brian Jamieson - Chairman, Mesoblast Limited Annual General Meeting 2008 (in PDF)
  • 2008-November-24
  • The CEO Transcript - Investor Briefing with Silviu Itescu, Executive Director, Mesoblast Limited (in PDF)
  • 2008-November-14
  • Frost & Sullivan Select Proprietary Technology Platform as U.S. Stem Cell Market Innovation of the Year (in PDF)
  • 2008-November-11
  • Proprietary Stem Cells for Heart Failure Highlighted at Major Cardiology Conference in United States (in PDF)
  • 2008-November-7
  • Mesoblast Featured at UBS Healthcare - Investor Conference (in PDF)
  • 2008-November-5
  • Bone Marrow Transplant Trial Using Proprietary Cell Therapy Receives United States FDA Clearance and Institutional Ethics Approval (in PDF)
  • 2008-October-31
  • Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF)
  • 2008-October-24
  • Notice of 2008 Annual General Meeting (in PDF)
  • 2008-October-13
  • First Heart Failure Patients Successfully Implanted in United States (in PDF)
  • 2008-October-8
  • Appendix 3Y - Change of Director's Interest Notice (in PDF)
  • 2008-September-30
  • Appendix 3Y - Change of Director's Interest Notice (in PDF)
  • 2008-September-30
  • Appendix 3Y - Change of Director's Interest Notice (in PDF)
  • 2008-September-30
  • Appendix 3Y - Change of Director's Interest Notice (in PDF)
  • 2008-September-30
  • Appendix 3Y - Change of Director's Interest Notice (in PDF)
  • 2008-September-25
  • UBS Life Sciences Investor Conference Features Angioblast (in PDF)
  • 2008-September-23
  • Mesoblast Commercial Leadership Featured at World Stem Cell Summit (in PDF)
  • 2008-September-17
  • FDA Grants Orphan Drug Designation for Use of Proprietary Stem Cells in Bone Marrow Transplants (in PDF)
  • 2008-September-4
  • Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF)
  • 2008-September-3
  • Appendix 3Y - Change of Director's Interest Notice (in PDF)
  • 2008-September-3
  • Appendix 3Y - Change of Director's Interest Notice (in PDF)
  • 2008-August-28
  • Appendix 4E - Preliminary Final Report Year Ending on 30 June 2008 (in PDF)
  • 2008-August-28
  • Mesoblast Reports Significant Achievements and Strong Financial Position (in PDF)
  • 2008-August-21
  • Mesoblast's Allogeneic, "Off-The-Shelf", Stem Cells Are Safe and Effective for Cervical Spine Fusion (in PDF)
  • 2008-August-12
  • Mesoblast's Stem Cells Regrow Knee Cartilage In Severe Post-Menopausal Osteoarthritis Company To Commercialise Product For Broader Knee Cartilage Markets (in PDF)
  • 2008-August-7
  • Mesoblast - National Electronic Media Coverage (in PDF)
  • 2008-August-6
  • Non-Healing Bones Repaired in Clinical Trial Using Adult Stem Cells (in PDF)
  • 2008-July-31
  • Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF)
  • 2008-July-21
  • The CEO Transcript - Investor Briefing with Silviu Itescu, Founder and Executive Director, Mesoblast Limited (in PDF)
  • 2008-July-16
  • Key Stem Cell Patent Granted in United States (in PDF)
  • 2008-July-10
  • Allogeneic Stem Cells Effectively Treat Eye Diseases (in PDF)
  • 2008-June-5
  • United States FDA Clears Phase 2 Trial for Congestive Heart Failure (in PDF)
  • 2008-May-13
  • Near-Term Commercialisation of Three Bone and Cartilage Products (in PDF)
  • 2008-April-29
  • Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF)
  • 2008-April-17
  • Mesoblast's Cells Show Long-lasting and Sustained Effect in Knee Osteoarthritis, Company to Commence Phase 2 Clinical Trail for Knee Cartilage Protection (in PDF)
  • 2008-April-9
  • Spinal Fusion Clinical Program Update, Accelerated Timetable to Registration Trial (in PDF)
  • 2008-April-7
  • U.S. Heart Attack Trial Update, 'Most Exciting Stem Cell Therapy In Heart Research Today' (in PDF)
  • 2008-February-27
  • Appendix 4D - Half Year Report for the Six Months to 31 December 2007 (in PDF)
  • 2008-February-27
  • Mesoblast Half Year Results; Company Well Resourced to Execute Clinical and Commercial Strategic Objectives (in PDF)
  • 2008-February-19
  • Agreement with Abbott for Catheter-Based Stem Cell Heart Failure Therapy (in PDF)
  • 2008-February-13
  • Highly Successful Results of Bone Repair Trial Show that Mesoblast's Stem Cells Promote and Repair Fracture Healing (in PDF)
  • 2008-January-31
  • Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF)
  • 2017
  • 2017 Announcements / Press Releases
  • 2016
  • 2016 Announcements / Press Releases
  • 2015
  • 2015 Announcements / Press Releases
  • 2014
  • 2014 Announcements / Press Releases
  • 2013
  • 2013 Announcements / Press Releases
  • 2012
  • 2012 Announcements / Press Releases
  • 2011
  • 2011 Announcements / Press Releases
  • 2010
  • 2010 Announcements / Press Releases
  • 2009
  • 2009 Announcements / Press Releases
  • 2007
  • 2007 Announcements / Press Releases


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Privacy Policy Statement   |   Disclaimer
    © Copyright 1996-2024 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.